-+ 0.00%
-+ 0.00%
-+ 0.00%

BridgeBio prices secondary offering of 5 million shares by KKR Genetic Disorder LP

PUBT·08/14/2026 11:30:25
Listen to the news
BridgeBio prices secondary offering of 5 million shares by KKR Genetic Disorder LP
  • BridgeBio priced an oversubscribed secondary offering of 5,000,000 common shares sold by KKR Genetic Disorder L.P.
  • No shares sold by BridgeBio. No proceeds to the company.
  • Offering expected to close Aug. 17, 2026, subject to customary closing conditions.
  • William Blair, Goldman Sachs, KKR Capital Markets acting as joint book-running managers.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BridgeBio Pharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608140730PRIMZONEFULLFEED9810176) on August 14, 2026, and is solely responsible for the information contained therein.